Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rhythm Pharmaceuticals (RYTM) Return on Assets (2021 - 2025)

Historic Return on Assets for Rhythm Pharmaceuticals (RYTM) over the last 6 years, with Q3 2025 value amounting to 0.44%.

  • Rhythm Pharmaceuticals' Return on Assets rose 2600.0% to 0.44% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.44%, marking a year-over-year increase of 2600.0%. This contributed to the annual value of 0.72% for FY2024, which is 2000.0% down from last year.
  • Rhythm Pharmaceuticals' Return on Assets amounted to 0.44% in Q3 2025, which was up 2600.0% from 0.48% recorded in Q2 2025.
  • Over the past 5 years, Rhythm Pharmaceuticals' Return on Assets peaked at 0.06% during Q2 2021, and registered a low of 0.93% during Q1 2024.
  • Over the past 5 years, Rhythm Pharmaceuticals' median Return on Assets value was 0.54% (recorded in 2023), while the average stood at 0.49%.
  • As far as peak fluctuations go, Rhythm Pharmaceuticals' Return on Assets crashed by -6000bps in 2022, and later surged by 4900bps in 2025.
  • Rhythm Pharmaceuticals' Return on Assets (Quarter) stood at 0.23% in 2021, then plummeted by -107bps to 0.47% in 2022, then dropped by -15bps to 0.54% in 2023, then dropped by -28bps to 0.69% in 2024, then surged by 37bps to 0.44% in 2025.
  • Its Return on Assets stands at 0.44% for Q3 2025, versus 0.48% for Q2 2025 and 0.43% for Q1 2025.